| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| epirubicinhydroklorid 200 mg/100 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cidofovir 375 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| epirubicinhydroklorid 10 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| kladribin 10 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| abciximab 10 mg/5 ml injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| fluorouracil (som fluorouracilnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| paracetamol 500 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| aciklovir (som aciklovirnatrium) 500 mg/20 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| aciklovir (som aciklovirnatrium) 1 g/40 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| aciklovir (som aciklovirnatrium) 250 mg/10 ml infusionvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cytarabin 1 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| adenosin 30 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cytarabin 100 mg/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| adenosin 6 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cytarabin 2 g/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cytarabin 500 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| epoetin alfa 40 000 enheter/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| bevacizumab 400 mg/16 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| cytarabin 500 mg/25 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| bevacizumab 100 mg/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| amikacin (som amikacinsulfat) 100 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| amikacin (som amikacinsulfat) 500 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| dalteparinnatrium 100 000 enheter/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| eptifibatid 20 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| eptifibatid 75 mg/100 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| esmololhydroklorid 100 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| argatrobanmonohydrat 250 mg/2,5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| vinorelbin (som vinorelbintartrat) 50 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| idarubicinhydroklorid 10 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| fosfenytoinnatrium 750 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| zikonotid (som zikonotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| idarubicinhydroklorid 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| triamcinolonacetonid 50 mg/5 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| zikonotid (som zikonotidacetat) 500 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| iduronat-2-sulfatas 6 mg/3 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| mekasermin 40 mg/4 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 1 g/40 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| medroxiprogesteronacetat 150 mg/ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| aspartinsulin 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| medroxiprogesteronacetat 500 mg/2,5 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| pegaspargas 3 750 enheter/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| humant insulin (som glargininsulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| rituximab 100 mg/10 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| rokuroniumbromid 100 mg/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| rokuroniumbromid 50 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| tinzaparinnatrium 40 000 enheter/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| paklitaxel 150 mg/25 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| paklitaxel 300 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| palonosetron (som palonosetronhydroklorid) 250 mikrogram/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 1 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| galsulfas 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| dinatriumpamidronat 15 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| lisproinsulin 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| rituximab 500 mg/50 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| laxkalcitonin 400 enheter/2ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 5 g/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 50 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| bovint insulin (som olösligt bovint insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natriumklorid 900 mg/100 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 200 mg/8 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| humant insulin (som humant lösligt insulin) 500 enheter/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| fenol 1,25 g/25 ml, olja för injektion, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| nitroglycerin 50 mg/50 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| järn (som järnsackaros) 50 mg/2,5 ml, injektionsvätska, lösning, flaska |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|
| ketamin (som ketaminhydroklorid) 1 g/10 ml, injektionsvätska, lösning, ampull |
Has unit of presentation |
False |
Vial (unit of presentation) |
Inferred relationship |
Some |
|